Ebglyss (lebrikizumab)
Australian Public Assessment Report
Device/Product Name
Ebglyss
Active ingredients
Lebrikizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-01192-1-1
Submission Type
New biological medicine
Decision
Approved